Search for a trial | Research with human participants

1 results

Phase II, Open-Label Study to Evaluate Safety and Explore Efficacy of Escalating Doses of Bevacizumab-IRDye800CW as an Optical Imaging Agent to Detect Cancer Tissue Delineation during Tumor Resection Surgery in Patients with Breast Cancer

Approved WMORecruitment stopped

The main objective of this study is to define the optimal dose of fluorescent tracer for intraoperative detection of tumor delineation during breast cancer surgery.